Vanberra Signal

Farsight Genome Systems

Curated by Signal

Diagnostic systems for pathology laboratories

Overview

Farsight Genome Systems develops diagnostic software systems for pathology laboratories. Its platform technology enables primary pathology labs to utilize next generation sequencing information for cancer diagnostics. The system is a combination of reagents and software, and is compatible with most commercially available instruments.

Key facts

Founded
2014

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of a device to measure the blood glucose level in premature infants

    Life Sciences TechnologyUnited States
  • Blockchain based-AI enabled platform to provide gene therapies

    Life Sciences TechnologyBoise, United States
  • AI-based vital signs and blood glucose screening tool

    Life Sciences TechnologySheridan, United States

About Farsight Genome Systems

What does Farsight Genome Systems do?

Farsight Genome Systems develops diagnostic software systems for pathology laboratories.

Where is Farsight Genome Systems headquartered?

Farsight Genome Systems is headquartered in Sunnyvale, United States.

When was Farsight Genome Systems founded?

Farsight Genome Systems was founded in 2014.

Which sector is Farsight Genome Systems in?

Farsight Genome Systems operates in Life Sciences Technology.

Who are Farsight Genome Systems's competitors?

Companies similar to Farsight Genome Systems include PREEMIEr Diagnostics, Healid, and RE.DOCTOR.